Kythera Biopharmaceutica Profile

0.10
0.00  0.00%
0%
0%

Conversion by Samuels Camille D of 2766 shares of Kythera Biopharmaceutica

Kythera Biopharmaceuticals insider trading alert for conversion of common stock by Samuels Camille D, the corporate stakeholder, on July 15, 2018. This event was filed by Kythera Biopharmaceutical with SEC on 2012-10-16. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Kythera Biopharmaceutica Summary

Kythera Biopharmaceuticals (KYTH) is traded on NASDAQ in USA. It is located in Kythera Biopharmaceuticals, Inc.Westlake Village, CA and employs 212 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.97 B. Kythera Biopharmaceuticals has 26.3 M outstanding shares of which 1.46 M shares are now shorted by private and institutional investors with about 0.0 trading days to cover. Kythera Biopharma currently holds about 184.85 M in cash with (77.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.04 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Kythera Biopharmaceutica Probability Of Bankruptcy

Ownership Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Jennison Associates LlcCommon Shares1.6 M119.2 M
Palo Alto Investors LpCommon Shares1.1 M84.4 M
View Kythera Biopharmaceutica Diagnostics

Key Fundamentals

Kythera Biopharmaceutica Against Markets

Current Ratings

Kythera Biopharmaceutica 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for Kythera Biopharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
KYTHERA Biopharmaceuticals, Inc., a clinicalstage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription solutions for the aesthetic medicine market in the United States and internationally. more
NameKythera Biopharmaceuticals
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressKythera Biopharmaceuticals, Inc.Westlake Village, CA
ExchangeNASDAQ
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.kytherabiopharma.com
Phone818 587 4500
Please see also Stocks Correlation. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">